Digital twins transforming drug development
About
TwinEdge
TwinEdge Bioscience is a techbio company dedicated to the development of digital twins for oncology drug discovery and development.
By delivering population-scale insight earlier in the drug development process, we enable our clients make better decisions regarding which translational programmes progress to clinical trials, and how those clinical trials are designed and run.
Combining cutting-edge computational biology, artificial intelligence, and personalized medicine, TwinEdge Bioscience is transforming how new cancer therapies are developed.
Using proprietary methodology, datasets obtained from patient tumour samples are combined with known mechanistic insights.
The resulting “avatars” are digitally actionable representations of the patients’ tumours, ready for testing with new drugs in “in-avatar” trials.
To replicate real-world clinical diversity, TwinEdge is creating the world’s largest population of digital twins, in turn enabling unprecedented large-scale clinical insight attranslational and early clinical decision points.
Who we are
Leadership team
Michael Prosser
- Formerly CBO at Crown Bioscience
- Commercial, Strategic and Operational leadership roles
- Worldwide track record of success in growing translational Pharma Services companies
Kevin Buyens PhD
- Formerly Head of Corporate Development and Strategy at Crown Bioscience
- Industry Consultant in Business Planning, M&A, Strategy
- 15+ years in Life Science product and strategy roles
Ioannis Xenarios PhD
- Professor at Universities of Lausanne, Geneva, CHUV
- Head of the Data Analysis for Health2030 Genome Centre
- Formerly Head of Translational Bioinformatics, Merck Serono
Bulak Arpat
- Formerly Director of In silico Drug Development at JSR Life Sciences
- Focus on development of translational/predictive tools using multiomic datasets
- 20+ years experience in computational biology
Bringing Together
Key Stakeholders
Data Partners
The TwinEdge Patient Avatar Collection leverages unique access to large, relevant and rich patient datasets, partnering with Commercial Knowledge Bases and Public Data Repositories.
Clients & Partners
TwinEdge is proud to be serving members of the Pharmaceutical and Biotechnology industries across Europe, North America and Asia, alongside Principal Investigators, Academia and Patient Foundations.
Validation Network
Working strategically with the world’s largest translational CROs, TwinEdge is able to direct clients and partners with truly unique, collection-agnostic access to broad collections of non-clinical models, including PDX, CDX, organoids and cell lines.